Repligen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. 

CEO
Olivier Dominique Loeillot
CEOOlivier Dominique Loeillot
Employees
1,778
Employees1,778
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1981
Founded1981
Employees
1,778
Employees1,778

RGEN Key Statistics

Market cap
7.59B
Market cap7.59B
Price-Earnings ratio
5.42K
Price-Earnings ratio5.42K
Dividend yield
Dividend yield
Average volume
805.26K
Average volume805.26K
High today
$140.45
High today$140.45
Low today
$133.50
Low today$133.50
Open price
$138.88
Open price$138.88
Volume
157.57K
Volume157.57K
52 Week high
$175.77
52 Week high$175.77
52 Week low
$102.97
52 Week low$102.97

Stock Snapshot

With a market cap of 7.59B, Repligen(RGEN) trades at $134.05. The stock has a price-to-earnings ratio of 5424.12.

As of 2026-02-12, Repligen(RGEN) stock has fluctuated between $133.50 and $140.45. The current price stands at $134.05, placing the stock +0.4% above today's low and -4.6% off the high.

The Repligen(RGEN)'s current trading volume is 157.57K, compared to an average daily volume of 805.26K.

In the last year, Repligen(RGEN) shares hit a 52-week high of $175.77 and a 52-week low of $102.97.

In the last year, Repligen(RGEN) shares hit a 52-week high of $175.77 and a 52-week low of $102.97.

RGEN News

Simply Wall St 5d
How Investors May Respond To Repligen Winning Backing For Its AI-Driven Bioprocessing Platform

In its fourth-quarter 2025 investor letter, Baron Health Care Fund disclosed that it had added Repligen Corporation as a new portfolio holding, citing the compa...

How Investors May Respond To Repligen Winning Backing For Its AI-Driven Bioprocessing Platform
Simply Wall St 6d
Reassessing Repligen Valuation After Recent Share Price Weakness

Advertisement What Repligen’s recent share performance might be telling investors Repligen (RGEN) has drawn attention after a recent pullback, with the stock...

Reassessing Repligen Valuation After Recent Share Price Weakness
Nasdaq 7d
RGEN Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Repligen Corp. (Symbol: RGEN) crossed below their 200 day moving average of $139.13, changing hands as low as $138.51 per shar...

RGEN Makes Notable Cross Below Critical Moving Average

Analyst ratings

78%

of 23 ratings
Buy
78.3%
Hold
21.7%
Sell
0%

People also own

Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.